Intraocular Pressure after Triamcinolone Acetonide Assisted Anterior Vitrectomy in Patients who Underwent Complicated Cataract Surgery

Triamcinolone acetonide (TA) is a corticosteroid that has been used for a variety of intraocular treatments, since a long time to treat many ophthalmic diseases. Also TA can be used in anterior segment surgery to help manage vitreous loss during complicated cataract surgery and also it has been widely used for staining the vitreous in pars plana vitrectomy. A lot of studies have reported an increased rate of ocular hypertension or glaucoma after the use of TA for intraocular treatments. Furthermore, vitreous loss rate is 1.92% during cataract surgery and it is important event for surgeons and patients. Herein, we report the 12-month follow-up results of IOP and BCVA in 27 patients who underwent TA-assisted anterior vitrectomy secondary to posterior capsule rupture.